Viatris is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases.
We have been included on number of award lists that demonstrate the impact we are making.
Every day, we rise to the challenge to make a difference and here’s how the Director, Corporate Development will make an impact:
The Director, Corporate Development is responsible for leading the evaluation and execution of strategic transactions, including mergers, acquisitions, partnerships, and other growth initiatives. This role serves as a trusted advisor to senior leadership, including the Executive Leadership Team (ELT) and Board, delivering high-quality analysis, clear recommendations, and driving cross-functional alignment to achieve corporate objectives. The position requires a highly capable deal professional with strong financial acumen, sound judgment, and the ability to independently manage complex, high-visibility initiatives in a fast-paced environment.
Key responsibilities for this role include:
Lead end-to-end financial analysis and valuation workstreams across strategic transactions, including M&A, licensing, and partnerships.
Build, refine, and oversee complex financial models that incorporate multiple scenarios, risks, and assumptions.
Drive transaction processes beyond valuation, including structuring, negotiations, and execution.
Synthesize cross-functional inputs into clear, concise, and actionable recommendations for senior leadership.
Apply independent judgment to challenge assumptions, identify opportunities, and surface risks.
Serve as a trusted partner to key internal stakeholders, including Commercial, R&D, IP, Finance, Tax, Treasury, HR, and Transformation/Integration teams.
Lead cross-functional discussions and alignment, often navigating competing priorities to drive decision-making.
Independently run meetings and workstreams with senior stakeholders to maintain deal momentum.
Manage relationships with external advisors, including investment banks, legal counsel, and consulting firms and ensure they deliver high-quality outputs aligned with transaction objectives and timelines.
Enhance Corporate Development processes, tools, and templates to improve efficiency, consistency, and execution discipline.
Develop and maintain transaction tracking mechanisms and reporting frameworks.
Manage multiple concurrent transactions and priorities effectively.
Demonstrate strong emotional intelligence and adaptability when navigating dynamic stakeholder environments.
Drive alignment across large, cross-functional teams and ensure timely execution of key milestones.
The minimum qualifications for this role are:
Bachelors degree required. Masters degree preferred.
6-10+ years of experience in pharmaceutical corporate development, investment banking, private equity or a related field
Advanced financial modeling and valuation expertise across a range of transaction types.
Demonstrated ability to independently lead complex, high-visibility projects.
Proven track record of influencing senior stakeholders and delivering executive-level presentations.
Strong strategic thinking and problem-solving skills, with the ability to identify risks and develop solutions.
Excellent communication skills, with attention to detail and clarity in both written and verbal formats.
Experience managing cross-functional teams and external advisors in transaction environments.
High degree of ownership, proactiveness, and intellectual curiosity.
Exact compensation may vary based on skills, experience, and location. The salary range for this position is $112,000 - $236,000.
At Viatris, we offer competitive salaries, benefits and an inclusive environment where you can use your experiences, perspectives and skills to help make an impact on the lives of others.
Viatris is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, national origin, religion, age, color, sex, sexual orientation, gender identity, gender expression, disability, or protected veteran status, or any other characteristic protected by local, state, or federal laws, rules, or regulations.
#LI-RemoteSkills Required
- Bachelors degree required
- Masters degree preferred
- 6-10+ years of experience in pharmaceutical corporate development, investment banking or private equity
- Advanced financial modeling and valuation expertise
- Proven track record of influencing senior stakeholders
- Experience managing cross-functional teams
Viatris Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Viatris and has not been reviewed or approved by Viatris.
-
Fair & Transparent Compensation — Compensation is frequently characterized as competitive and fair for the role, with “good pay” and “fair pay for job” appearing alongside references to competitive salary. This is reinforced by mentions of annual bonuses and overall satisfaction with pay levels in many roles and locations.
-
Healthcare Strength — Health coverage is portrayed as comprehensive, including private health insurance in some regions and broad medical support options. Mental health support is also emphasized through EAP access and coaching resources as part of the broader health offering.
-
Retirement Support — Retirement benefits appear robust, with references to defined contribution pension arrangements and a 401(k) with employer matching, plus options for different contribution types. Profit-sharing and long-service/loyalty awards further support longer-term financial value.
Viatris Insights
What We Do
Viatris is a global pharmaceutical company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer.







